A first-in-human clinical trial evaluating an investigational gene therapy targeting complement-mediated pathways in ...
The NYU Langone-Sage NDHCC will expand upon the work Sage Bionetworks has been doing for more than a decade, building infrastructure that makes collaborative biomedical research possible at scale.” — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results